Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes.

Mentrikoski MJ, Ma L, Pryor JG, McMahon LA, Yang Q, Spaulding BO, Scott GA, Wang HL, Xu H.

Mod Pathol. 2009 Dec;22(12):1582-7. doi: 10.1038/modpathol.2009.128. Epub 2009 Sep 4.

3.

Sentinel lymph node biopsy and melanoma biology.

Essner R.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2320s-2325s. Review.

4.

Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.

Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R.

Melanoma Res. 2007 Dec;17(6):393-9.

PMID:
17992123
5.

Sentinel node biopsy in melanoma.

Hauschild A, Christophers E.

Virchows Arch. 2001 Feb;438(2):99-106. Review.

PMID:
11253124
6.

Sentinel lymph nodes in cutaneous melanoma.

Prieto VG.

Clin Lab Med. 2011 Jun;31(2):301-10. doi: 10.1016/j.cll.2011.03.007. Review.

PMID:
21549243
7.

Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours.

Cochran AJ, Roberts A, Wen DR, Huang RR, Itakura E, Luo F, Binder SW.

Pathology. 2004 Oct;36(5):478-84. Review.

PMID:
15370119
8.

Sentinel lymph node biopsy for patients with diagnostically controversial Spitzoid melanocytic tumors?

Busam KJ, Pulitzer M.

Adv Anat Pathol. 2008 Sep;15(5):253-62. doi: 10.1097/PAP.0b013e31818323ac. Review.

PMID:
18724099
9.

Melanoma patient staging: histopathological versus molecular evaluation of the sentinel node.

Davids V, Kidson SH, Hanekom GS.

Melanoma Res. 2003 Jun;13(3):313-24. Review.

PMID:
12777989
10.

Update on the use of sentinel node biopsy in patients with melanoma: who and how.

Chao C, McMasters KM.

Curr Opin Oncol. 2002 Mar;14(2):217-20. Review.

PMID:
11880714
11.

Histologically ambiguous ("borderline") primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy.

Scolyer RA, Murali R, McCarthy SW, Thompson JF.

Arch Pathol Lab Med. 2010 Dec;134(12):1770-7. doi: 10.1043/2009-0612-RAR.1. Review.

PMID:
21128774
12.
13.

False-positive cells in sentinel lymph nodes.

Brennick JB, Yan S.

Semin Diagn Pathol. 2008 May;25(2):116-9. Review.

PMID:
18697715
14.

Atypical Spitzoid neoplasms: a review of potential markers of biological behavior including sentinel node biopsy.

McCormack CJ, Conyers RK, Scolyer RA, Kirkwood J, Speakman D, Wong N, Kelly JW, Henderson MA.

Melanoma Res. 2014 Oct;24(5):437-47. doi: 10.1097/CMR.0000000000000084. Review.

PMID:
24892957
15.

Pathology of malignant melanoma.

Liu V, Mihm MC.

Surg Clin North Am. 2003 Feb;83(1):31-60, v. Review.

PMID:
12691449
16.

The use of insulin like-growth factor II messenger RNA binding protein-3 in diagnostic pathology.

Findeis-Hosey JJ, Xu H.

Hum Pathol. 2011 Mar;42(3):303-14. doi: 10.1016/j.humpath.2010.06.003. Epub 2010 Oct 20. Review.

PMID:
20970161
17.

[Advancements in the diagnosis of melanoma].

Liszkay G.

Magy Onkol. 2015 Mar;59(1):68-72. Epub 2015 Feb 17. Review. Hungarian.

18.

Melanoma in children.

Paradela S, Fonseca E, Prieto VG.

Arch Pathol Lab Med. 2011 Mar;135(3):307-16. doi: 10.1043/2009-0503-RA.1. Review.

PMID:
21366453
19.

Role of immunohistochemistry in diagnosing tumors of cutaneous appendages.

Hoang MP.

Am J Dermatopathol. 2011 Dec;33(8):765-71; quiz 772-4. doi: 10.1097/DAD.0b013e31820a4837. Review.

PMID:
22112636
20.

Best practices in diagnostic immunohistochemistry: pleomorphic cutaneous spindle cell tumors.

Folpe AL, Cooper K.

Arch Pathol Lab Med. 2007 Oct;131(10):1517-24. Review.

PMID:
17922587

Supplemental Content

Support Center